FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282939886> ?p ?o ?g. }

• W4282939886 endingPage "1526" @default.
• W4282939886 startingPage "1520" @default.
• W4282939886 abstract "Anti-osteoporosis treatment following hip fractures may reduce the overall mortality rate. However, the effects of different drugs on mortality is still unclear. This population-based cohort study aimed to identify the degree of reduced mortality after various anti-osteoporosis regimens following hip fracture surgery. We conducted this cohort study to identify patients with newly diagnosed osteoporosis and hip fractures from 2009 to 2017 using the Taiwan National Health Insurance Research Database (NHIRD). The subsequent use of anti-osteoporosis medication following hip fracture surgery was collected and analyzed. National death registration records were retrieved to determine mortality. A total of 45,226 new cases of osteoporotic hip fracture were identified. Compared with patients who did not receive further treatment, patients who had ever used oral bisphosphonates (alendronate and risedronate, hazard ratio [HR] 0.81; 95% confidence interval [CI], 0.78-0.84), ibandronate (HR 0.76; 95% CI, 0.67-0.86), zoledronic acid (HR 0.70; 95% CI, 0.64-0.76), and denosumab (HR 0.64; 95% CI, 0.60-0.68) showed lower all-cause mortality rates. Patients treated with bisphosphonates had a lower mortality risk than those treated with selective estrogen receptor modulators (HR 0.81; 95% CI, 0.75-0.87). Patients treated with zoledronic acid showed a lower mortality risk than those treated with oral bisphosphonates (HR 0.89; 95% CI, 0.82-0.97). However, patients receiving denosumab and zoledronic acid did not show a significant difference in mortality (HR 0.94; 95% CI, 0.85-1.03). Different anti-osteoporosis treatments for postsurgical patients were associated with different levels of decline in mortality. Generally, longer durations of drug use were associated with lower mortality. © 2022 American Society for Bone and Mineral Research (ASBMR)." @default.
• W4282939886 created "2022-06-16" @default.
• W4282939886 creator A5009947103 @default.
• W4282939886 creator A5019623612 @default.
• W4282939886 creator A5036158256 @default.
• W4282939886 creator A5057176995 @default.
• W4282939886 creator A5079033604 @default.
• W4282939886 creator A5083775734 @default.
• W4282939886 date "2022-06-25" @default.
• W4282939886 modified "2023-10-15" @default.
• W4282939886 title "The Impact of Various Anti‐Osteoporosis Drugs on All‐Cause Mortality After Hip Fractures: A Nationwide Population Study" @default.
• W4282939886 cites W1970001479 @default.
• W4282939886 cites W1972254217 @default.
• W4282939886 cites W1993035292 @default.
• W4282939886 cites W2009726500 @default.
• W4282939886 cites W2026656096 @default.
• W4282939886 cites W2028195029 @default.
• W4282939886 cites W2031534650 @default.
• W4282939886 cites W2033929067 @default.
• W4282939886 cites W2039986085 @default.
• W4282939886 cites W2048445712 @default.
• W4282939886 cites W2051949877 @default.
• W4282939886 cites W2057409055 @default.
• W4282939886 cites W2061326496 @default.
• W4282939886 cites W2061450074 @default.
• W4282939886 cites W2070258192 @default.
• W4282939886 cites W2072473425 @default.
• W4282939886 cites W2073292208 @default.
• W4282939886 cites W2075065709 @default.
• W4282939886 cites W2093948624 @default.
• W4282939886 cites W2103305643 @default.
• W4282939886 cites W2106796320 @default.
• W4282939886 cites W2107177566 @default.
• W4282939886 cites W2119562205 @default.
• W4282939886 cites W2169583054 @default.
• W4282939886 cites W2201115531 @default.
• W4282939886 cites W2262934308 @default.
• W4282939886 cites W2265332327 @default.
• W4282939886 cites W2269943910 @default.
• W4282939886 cites W2515857301 @default.
• W4282939886 cites W2570324530 @default.
• W4282939886 cites W2735301415 @default.
• W4282939886 cites W2782383532 @default.
• W4282939886 cites W2789597034 @default.
• W4282939886 cites W2791156646 @default.
• W4282939886 cites W2794402771 @default.
• W4282939886 cites W2798247748 @default.
• W4282939886 cites W2893745569 @default.
• W4282939886 cites W2901346633 @default.
• W4282939886 cites W2924972170 @default.
• W4282939886 cites W2956669604 @default.
• W4282939886 cites W2968699264 @default.
• W4282939886 cites W2982081894 @default.
• W4282939886 cites W3203001964 @default.
• W4282939886 cites W4206712512 @default.
• W4282939886 doi "https://doi.org/10.1002/jbmr.4627" @default.
• W4282939886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35689432" @default.
• W4282939886 hasPublicationYear "2022" @default.
• W4282939886 type Work @default.
• W4282939886 citedByCount "9" @default.
• W4282939886 countsByYear W42829398862022 @default.
• W4282939886 countsByYear W42829398862023 @default.
• W4282939886 crossrefType "journal-article" @default.
• W4282939886 hasAuthorship W4282939886A5009947103 @default.
• W4282939886 hasAuthorship W4282939886A5019623612 @default.
• W4282939886 hasAuthorship W4282939886A5036158256 @default.
• W4282939886 hasAuthorship W4282939886A5057176995 @default.
• W4282939886 hasAuthorship W4282939886A5079033604 @default.
• W4282939886 hasAuthorship W4282939886A5083775734 @default.
• W4282939886 hasConcept C126322002 @default.
• W4282939886 hasConcept C141071460 @default.
• W4282939886 hasConcept C201903717 @default.
• W4282939886 hasConcept C207103383 @default.
• W4282939886 hasConcept C2776286101 @default.
• W4282939886 hasConcept C2776326535 @default.
• W4282939886 hasConcept C2776541429 @default.
• W4282939886 hasConcept C2777251235 @default.
• W4282939886 hasConcept C2778885795 @default.
• W4282939886 hasConcept C2908647359 @default.
• W4282939886 hasConcept C44249647 @default.
• W4282939886 hasConcept C71924100 @default.
• W4282939886 hasConcept C72563966 @default.
• W4282939886 hasConcept C99454951 @default.
• W4282939886 hasConceptScore W4282939886C126322002 @default.
• W4282939886 hasConceptScore W4282939886C141071460 @default.
• W4282939886 hasConceptScore W4282939886C201903717 @default.
• W4282939886 hasConceptScore W4282939886C207103383 @default.
• W4282939886 hasConceptScore W4282939886C2776286101 @default.
• W4282939886 hasConceptScore W4282939886C2776326535 @default.
• W4282939886 hasConceptScore W4282939886C2776541429 @default.
• W4282939886 hasConceptScore W4282939886C2777251235 @default.
• W4282939886 hasConceptScore W4282939886C2778885795 @default.
• W4282939886 hasConceptScore W4282939886C2908647359 @default.
• W4282939886 hasConceptScore W4282939886C44249647 @default.
• W4282939886 hasConceptScore W4282939886C71924100 @default.
• W4282939886 hasConceptScore W4282939886C72563966 @default.
• W4282939886 hasConceptScore W4282939886C99454951 @default.
• W4282939886 hasFunder F4320309618 @default.

• next